| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $139.3M | -5.9% |
| Cost of Revenue | $35.3M | -7.0% |
| Gross Profit | $104.0M | -5.5% |
| R&D Expense | $33.0M | -9.0% |
| SG&A Expense | $38.7M | -16.6% |
| Operating Income | -$35.8M | +29.4% |
| Pre-tax Income | -$28.5M | +31.5% |
| Income Tax | $398K | -37.1% |
| Net Income | -$28.9M | +31.6% |
| EPS (Basic) | -$0.68 | +32.7% |
| EPS (Diluted) | -$0.68 | +32.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.0M | +147.9% |
| Accounts Receivable | $24.6M | -13.9% |
| Current Assets | $205.7M | -9.9% |
| Total Assets | $228.4M | -9.0% |
| Current Liabilities | $82.8M | -6.1% |
| Total Liabilities | $88.9M | -2.9% |
| Stockholders' Equity | $139.4M | -12.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.5M | +55.1% |
| Capital Expenditures | $3.5M | +55.5% |
| Investing Cash Flow | $34.8M | +279.0% |
| Financing Cash Flow | -$20.4M | +12.4% |
| Free Cash Flow | $4.0M | +54.7% |